Shao et al. [32] innovated using the artemisinin analog SM934, which is water soluble and isolated from Artemisia annua, as an effective treatment against NLRP3 signaling activation in IBD both in vitro and in vivo. This evidence concerns the gene NLRP3 and inflammatory bowel disease.